Applied Clinical Trials to Sponsor Events at Partnerships
Applied Clinical Trials is pleased to announce our sponsorship of Partnerships in Clinical Trials' Partnership Hall of Famer Award, as well as its Clinical Operations Optimization track.
Applied Clinical Trials is pleased to announce our sponsorship of Partnerships in Clinical Trials' (PCT) Partnership Hall of Famer Award, as well as its Clinical Operations Optimization track. PCT will be held at the Boston Convention and Exhibition Center from April 22-25.
As part of our media sponsorship, Applied Clinical Trials will sponsor the Hall of Famer Award, which honors two individuals and/or companies that are engaged in a partnership that moves beyond the traditional transactional model to further drug development. Because of our long history of covering the outsourcing in drug development industry, we felt this award was a good fit for us to honor a Partnership Hall of Famer in a neutral forum. The nomination and award is open to any non-transactional partnership, including academia, patient organizations, and others. Nominations are open until February 9th, and you can submit them here. The award will be presented at the Partnerships Awards Ceremony on Thursday, April 23, 2015 at 5:45 pm.
We are also pleased to sponsor the Clinical Operations Optimization track, again because of our core focus of advancing clinical trial operations through authoritative information and education of the professionals in that area. We will be providing a post-event executive summary of the sessions in that track.
Applied Clinical Trials will also be exhibiting at the event, so please stop by! We look forward to meeting you there.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
